QNRX

Quoin Pharmaceuticals, Ltd.

SEC CIK 1671502
$4.46 −37.5% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
5
Most recent
Advertisement

At a glance

Insiders at QNRX have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Carter Denise P., QNRX's COO, spent $250K of their own money on 555,556 shares at $0, growing their stake 1180%.

Insider transaction history

Form 4 filings for QNRX, newest first
View on SEC EDGAR ↗
QNRX
Buy LANGER DENNIS · Director · Open-market purchase · filed Oct 15, 2025 ΔOwn +999%

Langer Dennis, QNRX's Director, spent $128.6K of their own money on 15,152 shares at $8, growing their stake 1515200%.

+$128.6K
15,152 sh @ $8
QNRX
Buy Carter Denise P. · Director, Chief Operating Officer · Open-market purchase · filed Dec 27, 2024 ΔOwn +999%

Carter Denise P., QNRX's COO, spent $250K of their own money on 555,556 shares at $0, growing their stake 1180%.

+$250K
555,556 sh @ $0
QNRX
Buy Myers Michael · Director, Chief Executive Officer · Open-market purchase · filed Dec 27, 2024 ΔOwn +999%

Myers Michael, QNRX's CEO, spent $250K of their own money on 555,556 shares at $0, growing their stake 1176%.

+$250K
555,556 sh @ $0
Advertisement
QNRX
Buy Dunn Gordon · Chief Financial Officer · Open-market purchase · filed Dec 27, 2024 ΔOwn +424%

Dunn Gordon, QNRX's CFO, spent $55K of their own money on 122,221 shares at $0, growing their stake 424%.

+$55K
122,221 sh @ $0
QNRX
Buy Culverwell Anthony James · Director · Open-market purchase · filed Dec 27, 2024 ΔOwn +999%

Culverwell Anthony James, QNRX's Director, spent $45K of their own money on 100,000 shares at $0, growing their stake 31546%.

+$45K
100,000 sh @ $0
Advertisement

About QNRX insider activity

This page tracks every recent Form 4 filed for Quoin Pharmaceuticals, Ltd. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is QNRX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Quoin Pharmaceuticals, Ltd. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.